CS logo
small CS logo
Leningrad Regional Oncology Dispensary

St Petersburg, Russian Federation

About Leningrad Regional Oncology Dispensary


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Leningrad Regional Oncology Dispensary


During the past decade, Leningrad Regional Oncology Dispensary conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Leningrad Regional Oncology Dispensary" #1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Myriad Genetic Laboratories, Inc." with 2 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator and "GOG Foundation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

Clinical Trials Conditions at Leningrad Regional Oncology Dispensary


According to Clinical.Site data, the most researched conditions in "Leningrad Regional Oncology Dispensary" are "Advanced Ovarian Cancer" (1 trials), "BRCA Mutated" (1 trials), "BRCA Mutation" (1 trials), "Cancer" (1 trials) and "Complete Response" (1 trials). Many other conditions were trialed in "Leningrad Regional Oncology Dispensary" in a lesser frequency.

Clinical Trials Intervention Types at Leningrad Regional Oncology Dispensary


Most popular intervention types in "Leningrad Regional Oncology Dispensary" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Olaparib 300mg tablets" (2 trials), "Darolutamide (Nubeqa, BAY1841788)" (1 trials) and "Placebo to match olaparib 300mg" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Leningrad Regional Oncology Dispensary


The vast majority of trials in "Leningrad Regional Oncology Dispensary" are 2 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Leningrad Regional Oncology Dispensary


Currently, there are NaN active trials in "Leningrad Regional Oncology Dispensary". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Leningrad Regional Oncology Dispensary, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Leningrad Regional Oncology Dispensary, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".